Physicochemical characterization of meloxicam-mannitol binary systems

被引:39
作者
Nassab, Parya Reisi
Rajko, Robert
Szabo-Revesz, Piroska
机构
[1] Univ Szeged, Dept Pharmaceut Technol, H-6720 Szeged, Hungary
[2] Univ Szeged, Dept Unit Operat & Environm Engn, H-6725 Szeged, Hungary
基金
新加坡国家研究基金会;
关键词
meloxicam; mannitol; dissolution; X-ray diffractometry; multivariate curve resolution (MCR); chemometrics;
D O I
10.1016/j.jpba.2006.02.055
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The dissolution behaviour of drugs remains one of the most challenging aspects in formulation development. The anti-inflammatory drug, meloxicarn (ME) has poor water solubility. The object of this experiment was to improve the rate of dissolution of meloxicarn in capsule form. In order to achieve this, mannitol was used as a carrier in different ratios, in physical mixtures and melted forms. Mannitol, a sugar alcohol, is a cheap and readily available excipient. Differential scanning calorimetry (DSC) and X-ray diffractometry were used to investigate the characteristics of meloxicam-mannitol binary systems. Multivariate curve resolution (MCR) as a chemometric method was applied to interpret the X-ray diffractograms. This is believed to be the first published use of this reasoning for this interpretation. According to the results, the amount of mannitol and the particle size of ME were important factors in the rate of dissolution. To the perfect dissolution of ME, the melt technology was used which resulted in mixed crystals. This technology was made by 10 parts of mannitol and 1 part of ME2 with about 6 mu m in average particle size. The interaction (adhesion) between mannitol and ME for physical mixtures was not enough to the perfect dissolution. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:1191 / 1197
页数:7
相关论文
共 24 条
[1]   Investigation of tenoxicam and γ-cyclodextrin binary and ternary complexes [J].
Aigner, Z ;
Kézsmárki, A ;
Kata, M ;
Novák, C ;
Erös, I .
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2002, 42 (3-4) :227-233
[2]   Spectroscopic studies of micro environment dictated structural forms of piroxicam and meloxicam [J].
Banerjee, R ;
Sarkar, M .
JOURNAL OF LUMINESCENCE, 2002, 99 (03) :255-263
[3]   Cyclooxygenase inhibitors - current status and future prospects [J].
Dannhardt, G ;
Kiefer, W .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2001, 36 (02) :109-126
[4]   Chemometrics applied to unravel multicomponent processes and mixtures - Revisiting latest trends in multivariate resolution [J].
de Juan, A ;
Tauler, R .
ANALYTICA CHIMICA ACTA, 2003, 500 (1-2) :195-210
[5]   Assessment of new constraints applied to the alternating least squares method [J].
deJuan, A ;
VanderHeyden, Y ;
Tauler, R ;
Massart, DL .
ANALYTICA CHIMICA ACTA, 1997, 346 (03) :307-318
[6]   Meloxicam inhibits the growth of colorectal cancer cells [J].
Goldman, AP ;
Williams, CS ;
Sheng, HM ;
Lamps, LW ;
Williams, VP ;
Pairet, M ;
Morrow, JD ;
DuBois, RN .
CARCINOGENESIS, 1998, 19 (12) :2195-2199
[7]  
Golub G.H., 2013, Matrix Computations, V4th
[8]   Study of thermal behaviour of sugar alcohols [J].
Gombás, A ;
Szabó-Révész, P ;
Regdon, G ;
Erös, I .
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2003, 73 (02) :615-621
[9]  
HASSAN HB, 2004, J INCL PHENOM MACRO, V50, P219, DOI DOI 10.1007/S10847-004-3124-7
[10]   COX-2 inhibitors [J].
Hawkey, CJ .
LANCET, 1999, 353 (9149) :307-314